CAD 0.04
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | -251.43 Thousand CAD | -286.0% |
2022 | 135.17 Thousand CAD | -28.09% |
2021 | 187.99 Thousand CAD | -65.7% |
2020 | 548.02 Thousand CAD | 93.01% |
2019 | 283.93 Thousand CAD | 244.2% |
2018 | 82.49 Thousand CAD | 173.98% |
2017 | 30.1 Thousand CAD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | -33.6 Thousand CAD | 175.82% |
2024 Q1 | -54.23 Thousand CAD | 19.71% |
2023 Q4 | -67.54 Thousand CAD | -2333.66% |
2023 Q2 | 524.00 CAD | -98.69% |
2023 FY | -251.43 Thousand CAD | -286.0% |
2023 Q1 | 39.89 Thousand CAD | 12.12% |
2023 Q3 | 3024.00 CAD | 477.1% |
2022 Q2 | 29.32 Thousand CAD | -19.82% |
2022 Q4 | 35.57 Thousand CAD | 5.58% |
2022 FY | 135.17 Thousand CAD | -28.09% |
2022 Q1 | 36.57 Thousand CAD | -11.03% |
2022 Q3 | 33.7 Thousand CAD | 14.92% |
2021 FY | 187.99 Thousand CAD | -65.7% |
2021 Q2 | 52.86 Thousand CAD | -14.24% |
2021 Q4 | 41.1 Thousand CAD | 26.98% |
2021 Q3 | 32.37 Thousand CAD | -38.76% |
2021 Q1 | 61.64 Thousand CAD | -49.33% |
2020 Q4 | 121.65 Thousand CAD | -14.44% |
2020 Q3 | 142.17 Thousand CAD | 170.42% |
2020 Q2 | 52.57 Thousand CAD | -72.56% |
2020 FY | 548.02 Thousand CAD | 93.01% |
2020 Q1 | 191.61 Thousand CAD | 79.34% |
2019 Q2 | 55.7 Thousand CAD | 17.48% |
2019 Q1 | 47.41 Thousand CAD | -14.75% |
2019 FY | 283.93 Thousand CAD | 244.2% |
2019 Q4 | 106.84 Thousand CAD | 44.44% |
2019 Q3 | 73.97 Thousand CAD | 32.8% |
2018 Q2 | 6467.00 CAD | 0.0% |
2018 Q3 | 20.4 Thousand CAD | 215.54% |
2018 FY | 82.49 Thousand CAD | 173.98% |
2018 Q4 | 55.61 Thousand CAD | 172.56% |
2018 Q1 | - CAD | -100.0% |
2017 Q4 | 12.54 Thousand CAD | 0.0% |
2017 FY | 30.1 Thousand CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Aion Therapeutic Inc. | -285.33 Thousand CAD | 11.882% |
Ayurcann Holdings Corp. | 8.46 Million CAD | 102.97% |
Blueberries Medical Corp. | 84.22 Thousand CAD | 398.523% |
The BC Bud Corporation | 59.5 Thousand CAD | 522.552% |
BioNxt Solutions Inc. | 372.24 Thousand CAD | 167.544% |
CordovaCann Corp. | 3.26 Million CAD | 107.69% |
Christina Lake Cannabis Corp. | 3.46 Million CAD | 107.254% |
Captor Capital Corp. | 16.93 Million CAD | 101.484% |
City View Green Holdings Inc. | -290.73 Thousand CAD | 13.52% |
1CM Inc. | 7.6 Million CAD | 103.305% |
Global Hemp Group Inc. | - CAD | Infinity% |
Greenway Greenhouse Cannabis Corporation | -335.37 Thousand CAD | 25.03% |
IM Cannabis Corp. | 9.84 Million CAD | 102.554% |
Lobe Sciences Ltd. | 772.82 Thousand CAD | 132.534% |
Maple Leaf Green World Inc. | -17.85 Thousand CAD | -1308.261% |
Mountain Valley MD Holdings Inc. | -346 Thousand CAD | 27.332% |
Nextleaf Solutions Ltd. | 1.24 Million CAD | 120.155% |
Pharmadrug Inc. | -26.21 Thousand CAD | -859.075% |
Captiva Verde Wellness Corp. | 163.43 Thousand CAD | 253.844% |
RAMM Pharma Corp. | -902.83 Thousand CAD | 72.151% |
RIV Capital Inc. | -958.27 Thousand CAD | 73.762% |
Revive Therapeutics Ltd. | -328.00 CAD | -76555.793% |
Red White & Bloom Brands Inc. | 29.48 Million CAD | 100.853% |
SLANG Worldwide Inc. | 18.61 Million CAD | 101.35% |
1933 Industries Inc. | -602.75 Thousand CAD | 58.287% |
Red Light Holland Corp. | 2.02 Million CAD | 112.444% |
Top Strike Resources Corp. | 2.84 Million CAD | 108.832% |
Xebra Brands Ltd. | -367.96 Thousand CAD | 31.67% |
Adastra Holdings Ltd. | 7.03 Million CAD | 103.576% |